TORONTO , Feb. 28, 2023 /CNW/ – Mimi’s Rock Corp. (TSXV: MIMI) (” MRC ” or the “Corporation “) is pleased to announce the successful completion of its previously-announced statutory plan of arrangement under the provisions of the Business Corporations Act ( Ontario ) (the ” Arrangement “) involving FitLife Brands, Inc. (” Parent “) and its wholly-owned subsidiary, 1000374984 Ontario Inc. (the ” Purchaser ” and, together with the Parent, the ” FitLife “).

Pursuant to the Arrangement, among other things, the Purchaser acquired all of the issued and outstanding common shares of the Corporation (the ” Common Shares “). The Arrangement became effective at 12:01 a.m. ( Toronto time) on February 28, 2023 (the ” Effective Time “), resulting in MRC becoming a wholly-owned subsidiary of the Purchaser.

Dayton Judd , CEO of FitLife commented, “We are excited to welcome Mimi’s Rock to the FitLife family.  We look forward to working closely with the talented team at Mimi’s Rock to help drive further growth and profitability for their brands.”

Under the terms of the Arrangement, each former shareholder of MRC is entitled to receive a cash consideration of $0.17 per Common Share (the ” Cash Consideration “). Further, under the Arrangement, all options to acquire Common Shares outstanding immediately prior to the Effective Time have been accelerated and cancelled in accordance with their terms.

In order to receive the Cash Consideration in exchange for their Common Shares, registered shareholders are reminded that they must complete, sign and return the letter of transmittal to TSX Trust Company, in its capacity as depositary under the Arrangement, together with their certificate(s) or DRS advice(s) representing their Common Shares, in accordance with the tender procedures described in the Circular (as defined below). Any Common Shares held in the CDSX system were automatically deposited under the Arrangement and the beneficial shareholders thereof will receive the Cash Consideration in respect of such Common Shares. If you have any questions or require more information with regard to the procedures for receiving the Cash Consideration, please contact TSX Trust Company, by (i) telephone at 1-866-600-5869 ( North America ) or 1-416-342-1091 (International), or (ii) email at [email protected] .

With the Arrangement now complete, MRC intends to cause its Common Shares to be delisted from the TSX Venture Exchange (the ” Exchange “) as soon as reasonably practicable following the closing of the Arrangement. In connection therewith, MRC intends to submit an application to the applicable securities regulators to cease to be a reporting issuer and to terminate its public reporting obligations.

Further details regarding the Arrangement are set out in MRC’s management information circular dated January 13, 2023 (the ” Circular “) which is available on SEDAR ( www.sedar.com ) under MRC’s issuer profile.

Advisors

Bloom Burton Securities acted as financial advisor and Bennett Jones LLP acted as legal advisor to MRC in connection with the Arrangement. Stikeman Elliott LLP acted as legal advisor to FitLife in connection with the Arrangement.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. ( www.mimisrock.com ) is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14 -Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada , and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Cautionary Statement on Forward-Looking Information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation based on expectations, estimates and projections as at the date of this news release. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Although the Corporation believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Corporation disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

FitLife to acquire 100% equity ownership for a cash purchase price of CDN $0.17 per MIMI’s share

Following a review of all alternative strategic options available, MIMI’s Board of Directors has

determined the acquisition provides the best value for Shareholders

Transaction has received unanimous approval of the Board and Special Committee of Mimi’s Rock

Shareholders of Mimi’s Rock holding approximately 47% of the outstanding shares have entered into

voting support agreements in support of the transaction

TORONTO, December 5, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV:MIMI OTCQB:MIMNF), is pleased to announce that it has entered into a definitive arrangement agreement dated December 4, 2022 (the “Arrangement Agreement”) whereby an affiliate of FitLife Brands, Inc. (“FitLife”; OTCPK:FTLF) has agreed to acquire all of the issued and outstanding common shares of Mimi’s Rock (the “Shares”) in exchange for cash consideration of CDN $0.17 per Share (the “Arrangement”), subject to customary closing conditions. The Arrangement is expected to be completed by way of a statutory plan of arrangement under the Business Corporations Act (Ontario).

The purchase price of CDN $0.17 per Share represents an enterprise value of the Company of approximately $27.2 million on the date hereof and a total equity value of the Company, on a fully-diluted basis, of approximately $9.1 million, following the repayment of outstanding debt and other financial obligations of the Company to be repaid from the proceeds upon the closing of the Transaction. The purchase price of CDN $0.17 per Share represents a premium of approximately 8.5% to the 30-day volume weighted average price (CDN $0.157) of the Shares on the TSX Venture Exchange (the “Exchange”) as of the close of market trading on December 2, 2022 (being the last trading day prior to the announcement of the Arrangement).

“Following a comprehensive review of the strategic and financing alternatives available to the Company, we have concluded the acquisition by FitLife provides our shareholders with the best currently achievable combination of an appropriate value for our shares and near-term liquidity, despite the continued strong performance of our brands.” said CEO, David Kohler.

Dave Grandin, Chair of the Special Committee remarked, “While we as a Board remained confident in the quality of our Brands and their continued success, after reviewing all the available options going forward, including significant risks and uncertainties in connection with the upcoming maturities of our outstanding debt instruments and the general conditions of the capital markets, we ultimately concluded that the Transaction represents the best outcome for our shareholders that was achievable with an acceptable degree of certainty and an appropriate valuation”.

Particulars of the Arrangement

Consideration

Under the terms of the Arrangement Agreement, shareholders of Mimi’s Rock (the “Shareholders”) will be entitled to receive cash consideration of CDN $0.17 in exchange for each Share held immediately prior to the effective time of the Arrangement.

Shareholder Approval and Support

The Arrangement will require the approval of the Shareholders at a special meeting expected to take place in February, 2023 (the “Mimi’s Rock Meeting”). In order to become effective, the Arrangement must be approved at the Mimi’s Rock Meeting by: (i) at least two-thirds of the votes cast by Shareholders on a resolution approving the Arrangement; and (ii) a simple majority of the votes cast by Shareholders on a resolution approving the Arrangement, excluding for this purpose the votes attached to the Shares held by persons required to be excluded for purposes of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (including the 8,507,750 Shares held by David Kohler, the Chief Executive Officer of the Company, which is not considered to be arm’s length to the Company).

Certain Shareholders, who collectively own or control, directly or indirectly, approximately 47% of the Shares, have entered into voting support agreements with affiliates of FitLife to, among other things, vote their Shares in favour of the Arrangement, subject to the provisions thereof.

Required Approvals and Conditions to Closing

The Arrangement is subject to, among other things, the approval of the Ontario Superior Court of Justice (Commercial List) by way of interim and final orders, and the satisfaction or waiver of certain closing conditions customary in transactions of this nature, including the absence of material adverse changes in thebusiness and affairs of Mimi’s Rock. Subject to the satisfaction of such conditions, the Arrangement is expected to close in the first quarter of 2023.

Board and Special Committee Approval

The board of directors of Mimi’s Rock (the “Board”) established a special committee of the Board (the “Special Committee”), comprised of independent members of the Board, to assist in the evaluation, supervision and negotiation of the Arrangement.

BDO Canada LLP (“BDO”) delivered a fairness opinion (the “Fairness Opinion”) to the Special Committee to the effect that, as of December 2, 2022, the consideration to be received by the securityholders of Mimi’s Rock (collectively, the “Securityholders”) pursuant to the Arrangement is fair, from a financial point of view, to such Securityholders. Based on, among other things, the unanimous recommendation of the Special Committee and the receipt of the Fairness Opinion, the Board unanimously approved the Arrangement, having determined that the Arrangement is in the best interests of Mimi’s Rock and fair to the Securityholders.

The full text of the Fairness Opinion, which describes, among other things, the assumptions made, procedures followed, factors considered and limitations and qualifications on the review undertaken, along with the terms and conditions of the Arrangement, will be included in the management information circular of Mimi’s Rock in connection with the Mimi’s Rock Meeting, which is expected to be mailed to the Shareholders in January, 2023.

The Board unanimously recommends that Shareholders vote “FOR” the Arrangement.

Other Terms

The Arrangement Agreement includes representations, warranties and covenants typical of a transaction of this nature, along with customary non-solicitation, right to match, and fiduciary-out provisions. In addition, Mimi’s Rock has agreed to pay a termination fee of CDN $1 million if the Arrangement Agreement is terminated in certain circumstances, including if Mimi’s Rock enters into an agreement with respect to a superior proposal or if the Board or Special Committee withdraws its recommendation with respect to the Arrangement.

Following the closing of the Arrangement, the Shares are expected to be de-listed from the Exchange.

The Arrangement Agreement, which describes the full particulars of the Arrangement, will be made available on SEDAR (www.sedar.com) under the issuer profile of Mimi’s Rock.

Advisors

Bloom Burton Securities Inc. acted as financial advisor to the Special Committee of Mimi’s Rock and Bennett Jones LLP is acting as legal advisor to Mimi’s Rock. An independent fairness opinion was provided to the Special Committee by BDO Canada LLP.

Stikeman Elliott LLP is serving as legal advisor to FitLife.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names. The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

More information about the Company is available on Mimi’s Rock’ website (www.mimisrock.com).

About FitLife

FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements for health conscious consumers. FitLife markets over 130 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health primarily through domestic and international GNC franchise locations as well as through more than 17,000 additional domestic retail locations and, increasingly, online. FitLife is headquartered in Omaha, Nebraska. For more information please visit the FitLife website at www.fitlifebrands.com .

For further information about Mimi’s Rock, please contact:
David Kohler
Chief Executive Officer
Tel. (905) 330 5081
[email protected]

Cautionary Statement Regarding Forward-Looking Information

This news release may contain forward-looking statements or “forward-looking information” within the meaning of applicable Canadian securities laws (“forward-looking statements”). Often, forward-looking statements, which are based on current expectations, estimates and projections about the industry and markets in which Mimi’s Rock operates, and beliefs of and assumptions made by Mimi’s Rock’ management, involve risks and uncertainties, which are difficult to predict and are not guarantees of future performance, that could significantly affect the financial results of Mimi’s Rock. The Arrangement Agreement contains conditions to closing and there is no assurance that these conditions will be fulfilled prior to the outside date provided therein. All statements, other than statements of historical facts, that are presented herein, or in response to questions or otherwise, that address activities, events or developments that may occur in the future, including such matters as activities related to Mimi’s Rock’s financial or operational projections and the growth of Mimi’s Rock’ businesses and operations (often, but not always, through the use of words or phrases, or the negative variations of those words or other comparable words of a future or forward- looking nature, including, but not limited to, “intends,” “plans,” “will likely,” “unlikely,” “believe,” “expect,” “seek,” “anticipate,” “estimate,” “continue,” “will,” “shall,” “should,” “could,” “may,” “might,” “predict,” “project,” “forecast,” “target,” “potential,” “forecast,” “goal,” “objective,” “guidance” and “outlook”), are forward looking statements. Readers are cautioned not to place undue reliance on forward-looking statements. Although Mimi’s Rock believes that in making any such forward-looking statement, Mimi’s Rock’s expectations are based on reasonable assumptions, any such forward-looking statement involves known and unknown risks and uncertainties that could cause results to differ materially from those projected in or implied by any such forward-looking statement, including but not limited to adverse changes in general economic or market conditions or changes in political conditions or federal, provincial or state laws and regulations and the ability of the parties to achieve all of the conditions to the closing in order to consummate the Arrangement (including obtaining any necessary shareholder, court and regulatory approvals for the Arrangement). Any forward-looking statement speaks only at the date on which it is made, and except as may be required by law, Mimi’s Rock does not undertake any obligation to update any forward-looking statement to reflect new events or circumstances after the date on which it is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for Mimi’s Rock to predict all of them, or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward- looking statement contained in this news release is expressly qualified in its entirety by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, November 7, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV:MIMI OTCQB:MIMNF) (the “Company“), an online dietary supplement and wellness company, announces its third quarter results for the three months ended September 30, 2022.

David Kohler, CEO, commented: “We are pleased the strategies  undertaken continue to drive such strong results. Q3 was 19% better in Y-O-Y revenue and we achieved over a 500% lift in adjusted EBITDA over 2021.”  In addition, “Margins are up, SG&A has declined, which combined with our revenue growth,  are all great trends. We are excited to have stacked our third consecutive quarter of growth and positive earnings.”

Third Quarter Highlights

The third quarter of 2022 reflected the continued uptrend, with both revenue and Adjusted EBITDA at levels not recorded since the first half of 2020.

Revenues in Q3 of 2022 were $10.2 million, compared to $8.6 million in Q3 2021, an increase of 18.6% over the prior year period.

EBITDA for Q3 2022 was $0.7 million, compared to $0.1 million in Q3 2021. As foreign exchange movements late in the quarter had an impact, Adjusted EBITDA, which adds back foreign exchange losses and non-cash stock-based compensation, was $1.2 million for Q3 of 2022, compared to just $0.2 million in the same period last year.

Third quarter 2022 performance also improved over the second quarter, resulting in the Company’s best quarterly performance in the last two years and second-best quarterly earnings since inception. 

Revenues were similarly strong over the last two quarters for the Company’s DTI business, as price increases and lower overall discounting resulted in considerable increases in the top line figure.  Revenues in the 2022 period were also achieved with higher overall average prices, thus gross margin was higher as the Company focused on increasing average revenue per unit by limiting the amount of promotional discounting.

The Company’s skin care businesses saw considerable improvement in top line sales during Q3 2022. Revenues from the skincare business in the current period were much improved over same period last year due to a strong Prime Day sales event in July.   

Gross margin for Q3 of 2022 was significantly improved at $7.8 million (76.0%) compared to $5.9 million (68.1%) for Q3 of 2021.

Online advertising in the period remained higher than historical levels mainly as a function of ongoing campaigns which have shown to drive higher volumes.  Advertising spend in the third quarter of 2022 was focused on key promotional days, including Amazon Prime Day in July, as well as towards driving efficiency and spend on top products.  Short term promotions and a focus on variations of core products have enabled the business to maintain momentum.  

General and administrative expenses were slightly higher in the current period compared to the same period last year due to approximately $0.2 million in one-time non-recurring costs in Q3 2022.  Excluding these one-time costs, Adjusted EBITDA for Q3 2022 would have otherwise been $1.4 million.  Despite the higher expenses in the current quarter, general and administrative expenses are lower for the year-to-date 2022 period when compared to the same period in 2021.

Unusually high foreign exchange losses, mostly unrealized at period end, contributed to a net loss of $0.1 million for Q3 of 2022 compared to a net loss of $0.3 million, compared to a net loss of $0.3 million for Q3 of 2021.

Summary of Quarterly Results

EBITDA¹ – Non-IFRS Financial Measures – see definition under “Overall Performance”

Conference Call

A conference call to discuss the financial results of the Company will be held on Tuesday, November 8 at 11:00 a.m. To participate in the conference call, please dial the number below and request to join the Mimi’s Rock Corp. financial results call:

Canada/USA TF: 1-800-319-4610

International Toll: +1-604-638-5340

Copies of the Company’s financial statements and management’s discussion and analysis can be obtained under the Company’s disclosure page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

This news release contains forward-looking statements and forward looking information (collectively “Forward-Looking Statements“) within the meaning of applicable securities laws. Often, but not always, Forward-Looking Statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

Please refer to the 2021 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA.

All Forward-Looking Statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these Forward-Looking Statements. All of the Company’s Forward-Looking Statements are qualified by the assumptions that are stated or inherent in such Forward-Looking Statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the Forward-Looking Statements.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in Forward-Looking Statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that Forward-Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Statements. All Forward-Looking Statements contained in this press release are given as of the date hereof and are based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any Forward Looking Statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

SOURCE Mimi’s Rock Corp.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, June 30, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) is pleased to announce the revocation of the previously announced failure-to-file cease trade order (the “FFCTO“) issued by the Ontario Securities Commission on May 6, 2022 as a result of the Company’s delay in filing its audited annual financial statements for the fiscal year ended December 31, 2021 and the related management’s discussion and analysis, and officer certifications for the same period (collectively, the “Required Filings“).

The Company filed the Required Filings on June 27, 2022. The Company has also filed its interim financial statements for the first quarter of 2022 on June 27, 2022.

A conference call to discuss the financial results of the Company will be held on Tuesday, July 5 at 11:00 a.m. To participate in the conference call, please dial the number below and request to join the Mimi’s Rock Corp. financial results call:

Canada/USA TF: 1-800-319-4610

International Toll: +1-604-638-5340

Copies of the Company’s financial statements and management’s discussion and analysis can be obtained under the Company’s disclosure page on SEDAR at www.sedar.com.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, June 27, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) an online dietary supplement and wellness company, today announced the filing of its annual audited financial statements for the year ended December 31, 2021 and its related management’s discussion and analysis, and officer certifications (collectively, the “Year End Filings“).

The Company also announced its first quarter financial results for the period ending March 31, 2022 (the “Q1 Financials“). With respect to the 2022 first quarter:

“Management has actively monitored volumes, supply chain constraints and pricing pressure, and has been pro-active in taking steps to improve our gross margins, with a significant improvement that translated not only into improved EBITDA, but also positive net earnings.” commented CEO, David Kohler. “Importantly, the business at this scale and with our newly implemented measures is generating positive cash flow from operations.”

First Quarter Highlights

The first quarter of 2022 showed significant improvement in both gross margin and earnings.

Revenues in Q1 of 2022 were $9.5 million, compared to $9.8 million in the same period last year.  

In market revenues for the Dr. Tobias supplements business were stronger in Q1 of 2022 compared to the same period in 2021. However, the Company’s skincare businesses revenues were lower compared to the same period last year due to considerable discounting in 2021, which drove top line revenue at the expense of margin.  While overall revenues were lower in Q1 of 2022, gross margin was higher compared to Q1 of 2021 as a focus on pricing and limited promotional pricing increased product profitability. 

Gross margin for Q1 of 2022 was $6.9 million (72.7%) compared to $6.7 million (68.6%) for Q1 of 2021.

Online advertising in Q1 of 2022 was considerably higher compared to the same period in 2021. This was primarily attributable to higher advertising spend on the primary Amazon market platforms and also considerable promotional efforts on other search and social media platforms designed to increase overall awareness.  Investments were also made to establish sales listings on major sites in certain foreign markets. 

EBITDA for Q1 of 2022 was $0.5 million, compared to $0.1 million Q1 of 2021. Similarly, Adjusted EBITDA, which adds back non-cash stock-based compensation and foreign exchange losses was $0.5 million for Q1 of 2022, compared to Adjusted EBITDA of $0.2 million for Q1 of 2021.

Net income for Q1 of 2022 was $0.2 million, compared to a net loss of $0.2 million for Q1 of 2021.

2021 Year End Audited Results

As previously announced, the Company’s year end audit process, and the associated filing of the Year End Filings, was delayed due to challenges associated with auditing inventories at third party warehouses.  There was no material impact to the Year End Filings as a result of this delay.

The Company’s performance in Q4 of 2021 was not as strong as originally projected due in part to a change in the Company’s advertising partners in October of last year.  Beginning mid-Q4 of 2021, the Company began to see increased momentum and volumes in its supplements business. However, as a result of a change in market conditions for its skincare businesses, the Company recognized a goodwill impairment loss of approximately $4.2 million in Q4 of 2021.  For the year ended December 31, 2021, the Company incurred a net loss of $5.0 million, compared to a net income of $2.3 million for the year ended December 31, 2020. 

Following the filing of the Year End Filings, the Company has initiated steps to seek revocation of the failure to file cease trade order (the “CTO“) issued against the Company by the Ontario Securities Commission on May 2, 2022. The CTO orders that general trading, whether direct or indirect, of the securities of the Company cease. The Company expects this to occur within a week of filing the Year End Filings and the Q1 Financials. However, there is no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all. 

Summary of Quarterly Results

 Conference Call

Management expects to announce a conference call promptly after the CTO is revoked.  At that time, financial results set out in the Q1 Financials and the Year End Filings will be discussed and questions will be taken.  Details of such conference call will be communicated once available.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, June 21, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) announced today that it is in the final stages of its year end audit and expects to complete the filing of its annual audited financial statements for the year ended December 31, 2021 and its related management’s discussion and analysis, and officer certifications (collectively, the “Required Filings“) imminently.

The Company remains under a failure to file cease trade order against the Company (“CTO“) by the Ontario Securities Commission (the “OSC“) which orders that general trading, whether direct or indirect, of the securities of the Company cease.  The Company does not expect an interruption of the operations of the Company during the CTO.

The Company’s year end audit process was delayed due to challenges with auditing inventories at third party warehouses. Management believes completion of its 2021 year end audit is imminent, with its Required Filings to be made as soon as possible thereafter.  Revocation of the CTO is expected to occur within a few days after the Required Filings are made. However, there is no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all. 

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, June 6, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) announced today that it expects to complete the filing of its annual audited financial statements for the year ended December 31, 2021 and its related management’s discussion and analysis, and officer certifications (collectively, the “Required Filings“) within the next few days.

The Company remains under a failure to file cease trade order against the Company (“CTO“) by the Ontario Securities Commission (the “OSC“) which orders that general trading, whether direct or indirect, of the securities of the Company cease.  The Company does not expect an interruption of the operations of the Company during the CTO.

Despite its efforts, the Company was not able to complete its year end audit process before the deadline of May 2, 2022, primarily due to unique challenges with auditing inventories at third party warehouses. Management anticipates completion of the audit within days with its Required Filings to be made shortly thereafter.  Revocation of the CTO is expected to occur within a few days after the Required Filings are made. However, there is no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all. 

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, May 24, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) announced today that it is close to finalization of work necessary to complete the filing of its annual audited financial statements for the year ended December 31, 2021 and its related management’s discussion and analysis, and officer certifications (collectively, the “Required Filings“) which were due to be filed on May 2, 2022 (the “Filing Deadline“).   

The Company remains under a failure to file cease trade order against the Company (“CTO“) by the Ontario Securities Commission (the “OSC“) which orders that general trading, whether direct or indirect, of the securities of the Company cease.  The Company does not expect an interruption of the operations of the Company during the CTO.

The Company continues to have a target date to make the Required Filings on or before May 27, 2022, however, circumstances beyond the Company’s control may require that the filings be made several days later, the week of May 30.  Revocation of the CTO is expected to occur within a few days after the Required Filings are made. However, there is no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all. 

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, May 2, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) continues to work diligently to complete the filing of its annual audited financial statements for the year ended December 31, 2021 and its related management’s discussion and analysis, and officer certifications (collectively, the “Required Filings“) which were due to be filed on May 2, 2022 (the “Filing Deadline“).     

The Company confirms that the Ontario Securities Commission (the “OSC“) has issued a failure to file cease trade order against the Company (“CTO“) which orders that general trading, whether direct or indirect, of the securities of the Company cease. A copy of the CTO has been posted to the OSC website.

Despite the CTO, a beneficial holder of a security of the Company who is not, and was not as of the date of the CTO, an insider or control person of the Company may sell securities of the Company acquired before the date of the CTO if: (a) the sale is made through a “foreign organized regulated market”, as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada; and (b) the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation. Holders of the Company’s securities are urged to consult with their own investment advisors or legal counsel about the implications of the CTO.

The Company does not expect an interruption of the operations of the Company during the CTO.

The Company anticipates that it will complete the Required Filings on or before May 27, 2022. Revocation of the CTO is expected to occur within a few days after the Required Filings are made. However, there is no assurance that the Company will be able to remedy its filing default and have the CTO lifted in a timely manner or at all. 

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, May 2, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) announced today that it will not be in a position to file its annual audited financial statements for the year ended December 31, 2021 and its related management’s discussion and analysis and officer certifications (collectively, the “Required Filings“) by today’s prescribed filing deadline of May 2, 2022 (the “Filing Deadline“).   

Despite its efforts, the Company has not been able to complete its year end audit process, primarily due to ongoing challenges with auditing certain aspects of the Company’s third party inventories, as well as staffing issues related to Covid.  Due to these challenges, the auditors of the Company are not able to complete the audit by the Filing Deadline.  During the process of completing the year end, the Company encountered certain novel and unanticipated audit issues relating to the physical observation of inventory at facilities used by third party e-commerce marketplaces.  These issues are ones faced by a number of e-commerce retailers concerning similar inventory assurance matters. These issues are in the process of being resolved but will cause the filing date to be beyond the Filing Deadline.  These challenges are assurance related and do not impact financial results.

Management does not expect the issues described above to impact the financial reporting for Q1 2022.  The Company will submit the Required Filings as soon as possible and anticipates doing so not later than May 27, 2022.

The Company recognizes that this delay may result in the issuance of a failure to file cease trade order against the Company.  In the event this occurs, the Company will issue further press release(s) with additional information.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

TORONTO, March 15, 2022 /CNW/ – Mimi’s Rock Corp., (the “Company“) (TSXV: MIMI) (OTCQB: MIMNF) announced today the official launch on Tmall and first sales in China of Dr. Tobias products, including the brand’s best-selling Colon 14-Day Cleanse, Deep Immune, Liver Cleanse and Apple Cider Vinegar Gummies.  The Company’s products are now being purchased directly by Chinese consumers.

After many months of collaboration with their counterparts in China, Mimi’s Rock successfully launched its storefront on Tmall, China’s largest eCommerce platform. Tmall (more formally, Taobao Mall) is Alibaba’s dedicated B2C platform with over 500 million buyers, 50,000 merchants, and which boasts 70,000 brands. As the largest retail site in Asia, Mimi’s Rock and its company of brands can now sell directly to hundreds of millions of customers throughout China.

“Expanding the portals and geographies for the Mimi’s Rock family of brands has been a top priority for us, as we look to other markets to augment our continued success selling on Amazon.  This move to Tmall is the right choice for our brands and gives us access to the largest market in the world,” said David Kohler, CEO of Mimi’s Rock. “After spending months navigating the regulatory framework, we are now pleased to report that our products are flowing to consumers.  In fact, we are already placing inventory replenishment orders, as the launch has been better than we anticipated.  We look forward to following shortly with our skin care lines as well.”

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Toronto, ON – February 23, 2022 – Mimi’s Rock Corp., (the “Company”) (TSXV: MIMI) (OTCQB: MIMNF) is pleased to announce its top selling supplements brand, Dr. Tobias, is expanding its product selection with Digestive Enzymes with Prebiotics & Probiotics to support gut health developed to meet growing market demand in the digestive health space.

Dr. Tobias has formulated an amazing 4 in 1 supplement to help optimize gut health. Dr. Tobias Digestive Enzymes with Probiotics and Prebiotics to help process difficult-to-digest food and offers relief from bloating, post-meal gas, and digestive discomfort. This combination of enzymes, pro, pre, and postbiotics supports nutrient absorption while reducing digestive inflammation and irritation. This in turn helps boost the body’s defense, recovery, and immune system functions.

“Our goal is to provide customers with top products to help maintain both healthy gut and immune systems from the Dr. Tobias brand. We are focused on delivering the high-quality products that our customers seek and providing premium supplements, as more people look to improve their health and wellness,” said Dave Kohler, CEO of Mimi’s Rock.

The Company is hosting an Instagram Live event where participants can learn more about how to maintain a healthy gut and incorporating vitamins and supplements into a healthy lifestyle.  Join members of our team for the Dr. Tobias Healthier Version of You event on Instagram Live Today @ 12:00p.m. EST @Drtobiashealth.

When a digestive system is not functioning optimally, it can limit the production of digestive enzymes which keep a gut healthy. Millions of Americans suffer from autoimmune issues which may stem from a faulty gut. When gut health is compromised it can affect the immune system which accounts for about eighty per cent of the body’s immune defense.

Digestive enzymes with pre- and probiotics are formulated to help women and men find relief from occasional bloating, gas, and discomfort. The product is designed to replenish the digestive enzymes that may decline with age and helps tackle hard to digest foods while supporting the gastrointestinal tract.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Toronto, ON – January 25, 2022 – Mimi’s Rock Corp., (the “Company”) (TSXV: MIMI) (OTCQB: MIMNF) is pleased to announce its top selling supplements brand, Dr. Tobias, is expanding its Canadian product selections with Dr. Tobias Vitamin D3 and Dr. Tobias Apple Cider Vinegar Gummies.

Dr. Tobias health supplements, including Dr. Tobias Omega 3 Fish Oil, Probiotics 30 Billion and Adult Multivitamin, are currently available on Amazon.ca. These products will be joined by Dr. Tobias Vitamin D-3 (to support bone and teeth health) and Dr. Tobias Apple Cider Vinegar (to aid in overall health and digestion). Canadian consumers can now enjoy these popular supplements as part of a healthier living regime.

“Our goal is to provide our Canadian customers with top products from the Dr. Tobias brand. As a Canadian based company, we are focused on delivering high-quality products here in Canada and internationally. We are happy to fill the demand for premium supplements as more people look to improve their health and wellness,” said Dave Kohler, CEO of Mimi’s Rock.

To learn more about how to incorporate vitamins and supplements into a healthy lifestyle, join members of our team and special guest Caleigh Rykiss (@caleighfit), Canadian Wellness Expert for the Dr. Tobias Healthier Version of You event on Instagram Live Wednesday January 26, 2022 @ 7:00 pm @Drtobiashealth.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. (www.mimisrock.com) is an online dietary supplement and wellness company which markets and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Dr. Tobias Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Statements

 This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

 Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

 Please visit www.mimisrock.com  or www.sedar.com  for the Company’s recent filings.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

Forward-Looking Statements
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Please refer to the 2020 Annual Financial Statements for more details on the Company’s calculation of EBITDA and adjusted EBITDA. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
[email protected]

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
[email protected]

TORONTO, Sept. 10, 2020 – Mimi’s Rock Corp. (TSXV: MIMI) (the “Company”), an online dietary supplement and wellness company, today announced that all resolutions voted on at the annual and special meeting of shareholders of the Company held on September 8, 2020 were approved by shareholders. Shareholders voted in favour of the re-election of each of the incumbent directors, namely Telfer Hanson (Chair), Bryan Pearson (Lead Independent Director), David Grandin, Norman Betts, Charmaine Crooks and David Kohler.

In addition, the Company today announced the cancellation of an aggregate of 750,000 options (“Options”) to purchase common shares in the capital of the Company (“Common Shares”) and the issuance of Options to various employees, officers and directors to purchase up to a total of 920,000 Common Shares. The issued Options will expire 5 years from the date of grant and were issued on terms pursuant to TSX Venture Exchange policy and the Company’s stock option plan.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names. The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com. All Natural Advice and Maritime Naturals products focus on skin and beauty care. Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act. All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Mimi’s Rock Corp.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
[email protected]

TORONTO, September 1, 2020 – Mimi’s Rock Corp. (TSXV:MIMI, OTCQB:MIMNF) (the “Company”), an online dietary supplement and wellness company, today announced the launch of a premium formula of hand sanitizer.

“We are keenly aware of the increasing global demand for hand sanitizer and the proliferation of inferior product in the market. Many products are hard on the skin, smell awful and leave an unpleasant residue. We have worked meticulously with our Canadian manufacturing partner, to create a hand sanitizer that we believe is one of the best on the market. With the successful launch in Canada under our All Natural Advice skin care brand, we intend to also distribute hand sanitizer in the US as soon as possible” said Dave Kohler, CEO. “We have initially launched an 8 oz size and will be coming to market in the near future with additional sizes and scents.”

New Dr Tobias Gummies

The Company also announced an extension to its lineup of vitamins.  The Dr Tobias brand will soon be entering the popular “vitamin gummies” space and will start with a strong line up of four products. All 4 products are expected to launch in the current quarter, in time for the busy Q4 selling season.

The new line will include:

• • Apple Cider Vinegar Gummy
  • Elderberry & Vitamin C Gummy
  • Joint Support Gummy
  • Hair Vitamin Gummy

Other recently completed launches by our Dr Tobias supplements brand:

• • Zinc 50mg
  • Elderberry Immune Support
  • Vitamin C 1000mg
  • Organics Green Complex
  • Magnesium Bisglycinay

We expanded our already strong Dr. Tobias immune defense portfolio to meet demands in the current global climate as it pertains to Covid-19.  The addition of these products are in direct response to the voice of our customers, who are looking for high quality offerings in these areas.

We continue to add distribution channels and products in countries around the world and will provide an update on these initiatives in early October.  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.

Mimi’s Rock Corp. is an online dietary supplement and wellness company which market and sells its products under the Dr. Tobias, All Natural Advice and Maritime Naturals brand names.  The Dr. Tobias brand features over 30 products, including the top-selling Colon 14-Day Cleanse and the #1 selling Omega 3 Fish Oil on Amazon.com.  All Natural Advice and Maritime Naturals products focus on skin and beauty care.  Products sold under the All Natural and Maritime Naturals brand names are made in Canada and registered with Health Canada and under the EU Cosmetics Act.  All Natural Advice has been featured on BNN as a top selling skincare brand in Canada, and has been rated the #1 Beauty Brand on Amazon Canada for the past four years.

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward- looking statements in this press release include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on the business and operations of the Company, the Company’s expected revenues, the expected increase in quarterly revenues and Adjusted EBITDA. Please refer to the Company’s 2019 Annual Financial Statements and MD&A for more details on the Company’s calculation of EBITDA and Adjusted EBITDA.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
[email protected]

TORONTO, August 26, 2020 – Mimi’s Rock Corp. (TSXV:MIMI, OTCQB:MIMNF) (the “Company”), an online dietary supplement and wellness company, today announced its financial results for the three months ended June 30, 2020.

Highlights

• $10.9 million revenue – Highest to date
• $1.6 million EBITDA – Highest to date
• $0.9 million after-tax net income

“The second quarter of 2020 financial results reflect the continued evolution of our business” said David Kohler, CEO. “Our positioning in the marketplace combined with our new product offerings, have resulted in our best results to date—and we are proud of what we have accomplished. We have seen that the COVID-19 virus has further accelerated consumer interest in shopping online. We are excited about the implications and expect growth to continue.”

Results of Operations for the Three Months Ended June 30, 2020

Net income for the second quarter of 2020 was $928,165 compared to a net loss of $1,240,051 in the same period in 2019. EBITDA for the second quarter of 2020 was $1,584,184, compared to EBITDA of $460,008 for the same period in 2019. Adjusted EBITDA (which excludes non-cash share-based compensation expenses, listing fees, foreign exchange gains (losses) and investment income) for the second quarter of 2020 was $1,573,165, ahead of the Adjusted EBITDA of $1,382,117 reported for the same period in 2019.

Revenues

Consolidated revenues for the second quarter of 2020 were $10,943,137, up 25% from revenues of $8,770,904 in the same period in 2019. Revenues were $10,943,137 for the three months ended June 30, 2020 compared to revenues of $8,770,904 for the period ended June 30, 2019. Revenues in the comparative 2019 period represent revenues from the DTI business only as the skin care businesses, All Natural and Maritime Naturals, were acquired in December 2019.

DTI, the core dietary supplements business, saw an improvement in its financial performance in the second quarter of 2020, indicating that it has completed its recovery from a difficult fourth quarter of 2019. Management expects the revenues of this business to experience some fluctuation on a quarter-to-quarter basis, but ultimately continue to grow throughout 2020 with the launch of new complementary products and expansion into additional geographic territories. Also, revenues from the skin care businesses are expected to continue to grow as the products enter the U.S. market.

Selling and Marketing Expense

The Company incurred selling and marketing expenses of $4,788,764, or approximately 43.8% of revenue, for the second quarter of 2020, compared to $3,523,242, or 40.2% of revenue, for the same period in 2019. In the 2019 period, management consciously scaled back online advertising to evaluate returns on investment. In Q2 2020, the level of online advertising was increased as management had become confident that its refined marketing strategy was gaining traction in the marketplace.

General and Administrative Expense

General and administrative expenses for the three months ended June 30, 2020 were $1,272,825, compared to $1,302,960 for the same period in 2019. General and administrative expenses consist primarily of salaries and benefits, professional fees, occupancy costs and insurance. General and administrative expenses are relatively comparable to the same period in 2019 due to the fact that staff and operational costs are relatively stable. General and administrative expenses are expected to remain relatively fixed for foreseeable future periods.

Interest Expense and Financing Costs

Interest and financing costs of $180,991 were incurred during the three months ended June 30, 2020, compared to $533,475 for the three months ended June 30, 2019. Interest and financing expenses have decreased significantly in 2020 periods compared to 2019 primarily due to renegotiations of the senior debt facility as well as lower interest rates and non-cash charges related to amortization of finance costs incurred in securing the loan.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

About Mimi’s Rock Corp.:

Mimi’s Rock Corp. is an online dietary supplement and wellness company operating under the Dr. Tobias brand. The brand features over 30 products including the top selling colon cleansing product and the #1 selling Omega 3 Fish Oil on Amazon.com. Mimi’s Rock currently serves customers in the United States and has rapid growth plans to expand into other markets. For more information, visit https://mimisrock.com.

Forward-Looking Information

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects”, or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or describes a “goal”, or variation of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. The forward- looking statements in this press release include, but are not limited to, statements regarding the impact of the COVID-19 pandemic on the business and operations of the Company, the Company’s expected revenues, the expected increase in quarterly revenues and Adjusted EBITDA. Please refer to the Company’s 2019 Annual Financial Statements and MD&A for more details on the Company’s calculation of EBITDA and Adjusted EBITDA.

All forward-looking statements reflect the Company’s beliefs and assumptions based on information available at the time the statements were made. Actual results or events may differ from those predicted in these forward-looking statements. All of the Company’s forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions listed below. Although the Company believes that these assumptions are reasonable, this list is not exhaustive of factors that may affect any of the forward-looking statements.

Forward-looking statements involve known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, prediction, projection, forecast, performance or achievements expressed or implied by the forward-looking statements, including risks relating to: the Company’s reliance on strength of reputation and brands, third-party manufacturing, transportation and distribution, the Company’s ability to protect its intellectual property, the Company’s reliance on e-commerce sites, disruption or breaches in information technology systems, the successful integration subsequent to acquisitions, litigation, volatility in the market price, the inability to successfully implement growth strategy on a timely basis, difficulty expanding sales in targeted international markets, changes in general economic conditions, the Company’s ability to service its debt obligations, management of growth, reliance on management, conflicts of interest, local and foreign tax matters, liquidity, currency and other financial risks, potential product liability or other regulatory claims, product recalls, the need to develop and innovate products, changes in legal and regulatory standards, competition, operating risk and insurance coverage, natural disasters, unusual weather and geo-political events, the effect of COVID-19 on operations and other risks relating to the business and industry of the Company that are detailed from time to time in the Company’s filings with the Canadian provincial securities regulators.

Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. All forward- looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise, except in accordance with applicable securities laws.

Please visit www.mimisrock.com or www.sedar.com for the Company’s recent filings.

For further information, please contact:

David Kohler, CEO
905-330-5081
[email protected]

David Kohler, CEO, 905-330-5081, [email protected] CNW Group 2020

Telfer Hanson, Executive Chairman, 416-230-3003, [email protected] CNW Group 2020